AIM: To evaluate the protective effects of preconditioning by alpha-lipoic acid (LA) in patients undergoing hepatic resection under inflow occlusion of the liver. METHODS: Twenty-four patients undergoing liver resection for various reasons either received 600 mg LA or NaCl 15 min before transection performed under inflow occlusion of the liver. Blood samples and liver wedge biopsy samples were obtained after opening of the abdomen immediately after inflow occlusion of the liver, and 30 min after the end of inflow occlusion of the liver. RESULTS: Serum levels of aspartate transferase and alanine transferase were reduced at all time points in patients who received LA in comparison to those who received NaCL. This was accompanied by reduced histomorphological features of oncosis. We observed TUNEL-positive hepatocytes in the livers of the untreated patients, especially after 30 min of ischemia. LA attenuated this increase of TUNEL-positive hepatocytes. Under preconditioning with LA, ATP content was significantly enhanced after 30 min of ischemia and after 30 min of reperfusion. CONCLUSION: This is the first report on the potential for LA reducing ischemia/reperfusion injury (IRI) of the liver in humans who were undergoing liver surgery. Beside its simple and rapid application, side effects did not occur. LA might therefore represent a new strategy against hepatic IRI in humans.
AIM: To evaluate the protective effects of preconditioning by alpha-lipoic acid (LA) in patients undergoing hepatic resection under inflow occlusion of the liver. METHODS: Twenty-four patients undergoing liver resection for various reasons either received 600 mg LA or NaCl 15 min before transection performed under inflow occlusion of the liver. Blood samples and liver wedge biopsy samples were obtained after opening of the abdomen immediately after inflow occlusion of the liver, and 30 min after the end of inflow occlusion of the liver. RESULTS: Serum levels of aspartate transferase and alanine transferase were reduced at all time points in patients who received LA in comparison to those who received NaCL. This was accompanied by reduced histomorphological features of oncosis. We observed TUNEL-positive hepatocytes in the livers of the untreated patients, especially after 30 min of ischemia. LA attenuated this increase of TUNEL-positive hepatocytes. Under preconditioning with LA, ATP content was significantly enhanced after 30 min of ischemia and after 30 min of reperfusion. CONCLUSION: This is the first report on the potential for LA reducing ischemia/reperfusion injury (IRI) of the liver in humans who were undergoing liver surgery. Beside its simple and rapid application, side effects did not occur. LA might therefore represent a new strategy against hepatic IRI in humans.
Authors: J Soeda; S Miyagawa; K Sano; J Masumoto; S Taniguchi; S Kawasaki Journal: Am J Physiol Gastrointest Liver Physiol Date: 2001-10 Impact factor: 4.052
Authors: Manfred Bilzer; Andreas Baron; Rolf Schauer; Christian Steib; Stefan Ebensberger; Alexander L Gerbes Journal: Digestion Date: 2002 Impact factor: 3.216
Authors: Christian Müller; Friedrich Dünschede; Elke Koch; Angelika M Vollmar; Alexandra K Kiemer Journal: Am J Physiol Gastrointest Liver Physiol Date: 2003-06-19 Impact factor: 4.052
Authors: Mahmoud Abu-Amara; Kurinchi Selvan Gurusamy; George Glantzounis; Barry Fuller; Brian R Davidson Journal: Cochrane Database Syst Rev Date: 2009-10-07
Authors: Liliane Mpabanzi; Kim M C van Mierlo; Massimo Malagó; Cornelis H C Dejong; Dimitrios Lytras; Steven W M Olde Damink Journal: HPB (Oxford) Date: 2012-10-22 Impact factor: 3.647
Authors: Ekhlas H Abdel-Hafeez; Azza K Ahmad; Ahlam M Abdulla; Soha Aabdel-Wahab; Fadia A Mosalem Journal: Parasitol Res Date: 2012-03-08 Impact factor: 2.289
Authors: Filipe V Duarte; João A Amorim; Ana T Varela; João S Teodoro; Ana P Gomes; Rodrigo A Cunha; Carlos M Palmeira; Anabela P Rolo Journal: Purinergic Signal Date: 2016-11-15 Impact factor: 3.765
Authors: Sally P Stabler; Jeevan Sekhar; Robert H Allen; Heidi C O'Neill; Carl W White Journal: Free Radic Biol Med Date: 2009-07-17 Impact factor: 7.376